Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 6/20 | 0.41 |
| ▸ | MTOR | P42345 | 4/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | DGKZ | Q13574 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.36 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.36 |
| ▸ | PRKDC | P78527 | 3/20 | 0.35 |
| ▸ | MAT2A | P31153 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.34 |
| ▸ | USP14 | P54578 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | BCL6 | P41182 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.32 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27252322 | 0.87 | GSK3B (0.37) | PIK3CAMTORGSK3BDGKZPIK3CD | |
| SCHEMBL29310609 | 0.85 | GSK3B (0.36) | PIK3CAMTORGSK3BDGKZPIK3CD | |
| SCHEMBL29314306 | 0.78 | PIK3CA (0.39) | PIK3CAMTORGSK3BPIK3CDPIK3CG | |
| SCHEMBL27252321 | 0.77 | GSK3B (0.41) | PIK3CAMTORGSK3BPIK3CDPIK3CG | |
| SCHEMBL27250770 | 0.77 | PDE10A (0.44) | PIK3CAMTORGSK3BMAT2AELANE | |
| SCHEMBL27251709 | 0.76 | ADORA2A (0.41) | PIK3CAMTORGSK3BPRKDCPDE4B | |
| SCHEMBL30827633 | 0.76 | ADORA2A (0.41) | PIK3CAMTORGSK3BPRKDCPDE4B | |
| SCHEMBL29311431 | 0.75 | PDE3B (0.44) | PIK3CAPIK3CDPIK3CGBCL6PIK3CB | |
| SCHEMBL29311430 | 0.72 | GRM2 (0.43) | DGKZPDE4BPDE4DADORA2A | |
| SCHEMBL24405558 | 0.72 | PGR (0.43) | PIK3CAMTORGSK3BPIK3CDPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228469-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228469-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | PCSK9, PCSK7, PCSK6 | PIK3CA 1197/4885MTOR 2200/4885GSK3B 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.